FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3164705241> ?p ?o ?g. }

• W3164705241 endingPage "2199" @default.
• W3164705241 startingPage "2189" @default.
• W3164705241 abstract "To assess the incidence, presentation, and management of rheumatoid arthritis (RA) in patients with HIV, including the use of disease-modifying antirheumatic drugs (DMARDs) in this immunosuppressed population.Patients included in this study were from the Veterans Aging Cohort Study, a longitudinal cohort of veterans with HIV and age-, race-, and site-matched uninfected veterans. We identified all patients who had ≥1 rheumatologist-generated International Classification of Diseases, Ninth Revision (ICD-9) or Tenth Revision (ICD-10) code for RA and whose serum samples were tested for rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibodies. To further confirm the diagnosis of RA, medical charts were reviewed to verify whether patients met the American College of Rheumatology/European Alliance of Associations for Rheumatology 2010 criteria for RA. We recorded DMARD use and adverse effects during the first contiguous course of treatment (i.e., >6 months of no interruption in DMARD treatment).This study included 56,250 patients with HIV and 116,944 uninfected individuals over 2,384,541 person-years. Of the 2,748 individuals in this cohort who were reviewed for a diagnosis of RA based on ICD-9 or ICD-10 codes, incident RA was identified in 215 individuals, including 21 patients with HIV. The incidence rate ratio of RA for patients with HIV compared to uninfected individuals was 0.29 (95% confidence interval 0.19-0.48). Most of the patients diagnosed as having RA (88%) were seropositive for RA-associated autoantibodies (RF and/or anti-CCP). However, high autoantibody titers were less frequent in RA patients with HIV compared to RA patients without HIV. In total, 5% of RA patients with HIV (1 of 21) had both high titers of anti-CCP and high titers of RF, compared to 41% of uninfected individuals (81 of 194). DMARDs were prescribed in 71% of RA patients with HIV (15 of 21) compared to 94% of RA patients without HIV (183 of 194). There was no indication that the DMARD safety profile was worse among RA patients with HIV who were prescribed DMARDs (n = 10 assessed) compared to RA patients without HIV who were prescribed DMARDs (n = 158 assessed).In this cohort, incident RA was less common in patients with HIV compared to uninfected individuals. Moreover, compared to RA patients without HIV, the seropositivity rate and titers of RA-specific autoantibodies were lower among RA patients with HIV, and those with HIV were prescribed DMARDs less frequently than those without HIV." @default.
• W3164705241 created "2021-06-07" @default.
• W3164705241 creator A5000519502 @default.
• W3164705241 creator A5018099060 @default.
• W3164705241 creator A5025733523 @default.
• W3164705241 creator A5076370147 @default.
• W3164705241 creator A5087940101 @default.
• W3164705241 creator A5091764018 @default.
• W3164705241 date "2021-10-28" @default.
• W3164705241 modified "2023-10-16" @default.
• W3164705241 title "Incident Rheumatoid Arthritis in HIV Infection: Epidemiology and Treatment" @default.
• W3164705241 cites W1588610010 @default.
• W3164705241 cites W1995799033 @default.
• W3164705241 cites W2007359807 @default.
• W3164705241 cites W2010430808 @default.
• W3164705241 cites W2013703920 @default.
• W3164705241 cites W2021252940 @default.
• W3164705241 cites W2051515991 @default.
• W3164705241 cites W2053819767 @default.
• W3164705241 cites W2068357814 @default.
• W3164705241 cites W2101729820 @default.
• W3164705241 cites W2106274242 @default.
• W3164705241 cites W2109702390 @default.
• W3164705241 cites W2110177517 @default.
• W3164705241 cites W2118389117 @default.
• W3164705241 cites W2125377515 @default.
• W3164705241 cites W2128952811 @default.
• W3164705241 cites W2142004396 @default.
• W3164705241 cites W2165216704 @default.
• W3164705241 cites W2169097752 @default.
• W3164705241 cites W2169560724 @default.
• W3164705241 cites W2169868751 @default.
• W3164705241 cites W2292697618 @default.
• W3164705241 cites W2313039815 @default.
• W3164705241 cites W2507882019 @default.
• W3164705241 cites W2509702101 @default.
• W3164705241 cites W2582253006 @default.
• W3164705241 cites W2608603956 @default.
• W3164705241 cites W2738924373 @default.
• W3164705241 cites W2753090874 @default.
• W3164705241 cites W2765222136 @default.
• W3164705241 cites W2800826112 @default.
• W3164705241 cites W2809024468 @default.
• W3164705241 doi "https://doi.org/10.1002/art.41802" @default.
• W3164705241 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34042306" @default.
• W3164705241 hasPublicationYear "2021" @default.
• W3164705241 type Work @default.
• W3164705241 sameAs 3164705241 @default.
• W3164705241 citedByCount "7" @default.
• W3164705241 countsByYear W31647052412021 @default.
• W3164705241 countsByYear W31647052412022 @default.
• W3164705241 countsByYear W31647052412023 @default.
• W3164705241 crossrefType "journal-article" @default.
• W3164705241 hasAuthorship W3164705241A5000519502 @default.
• W3164705241 hasAuthorship W3164705241A5018099060 @default.
• W3164705241 hasAuthorship W3164705241A5025733523 @default.
• W3164705241 hasAuthorship W3164705241A5076370147 @default.
• W3164705241 hasAuthorship W3164705241A5087940101 @default.
• W3164705241 hasAuthorship W3164705241A5091764018 @default.
• W3164705241 hasConcept C107130276 @default.
• W3164705241 hasConcept C120665830 @default.
• W3164705241 hasConcept C121332964 @default.
• W3164705241 hasConcept C126322002 @default.
• W3164705241 hasConcept C159654299 @default.
• W3164705241 hasConcept C163764329 @default.
• W3164705241 hasConcept C198451711 @default.
• W3164705241 hasConcept C203014093 @default.
• W3164705241 hasConcept C2776232647 @default.
• W3164705241 hasConcept C2777575956 @default.
• W3164705241 hasConcept C2908647359 @default.
• W3164705241 hasConcept C61511704 @default.
• W3164705241 hasConcept C71924100 @default.
• W3164705241 hasConcept C72563966 @default.
• W3164705241 hasConcept C99454951 @default.
• W3164705241 hasConceptScore W3164705241C107130276 @default.
• W3164705241 hasConceptScore W3164705241C120665830 @default.
• W3164705241 hasConceptScore W3164705241C121332964 @default.
• W3164705241 hasConceptScore W3164705241C126322002 @default.
• W3164705241 hasConceptScore W3164705241C159654299 @default.
• W3164705241 hasConceptScore W3164705241C163764329 @default.
• W3164705241 hasConceptScore W3164705241C198451711 @default.
• W3164705241 hasConceptScore W3164705241C203014093 @default.
• W3164705241 hasConceptScore W3164705241C2776232647 @default.
• W3164705241 hasConceptScore W3164705241C2777575956 @default.
• W3164705241 hasConceptScore W3164705241C2908647359 @default.
• W3164705241 hasConceptScore W3164705241C61511704 @default.
• W3164705241 hasConceptScore W3164705241C71924100 @default.
• W3164705241 hasConceptScore W3164705241C72563966 @default.
• W3164705241 hasConceptScore W3164705241C99454951 @default.
• W3164705241 hasFunder F4320306127 @default.
• W3164705241 hasFunder F4320308971 @default.
• W3164705241 hasFunder F4320337330 @default.
• W3164705241 hasFunder F4320337338 @default.
• W3164705241 hasIssue "12" @default.
• W3164705241 hasLocation W31647052411 @default.
• W3164705241 hasLocation W31647052412 @default.
• W3164705241 hasOpenAccess W3164705241 @default.
• W3164705241 hasPrimaryLocation W31647052411 @default.

• next